Expression of ceruloplasmin in the retina: Induction after optic nerve crush

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 1, 1998, Pages 157-163

  Levin, Leonard A ^a   Geszvain, Kati M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; LIVER; NERVE CELL NECROSIS; NERVE CRUSH; NERVE FIBER TRANSECTION; NONHUMAN; NORTHERN BLOTTING; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; RETINA; RETINA BIPOLAR GANGLION CELL; RETINA GANGLION CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; AXOTOMY; BLOTTING, NORTHERN; CERULOPLASMIN; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; LIVER; NERVE CRUSH; OPTIC NERVE; POLYMERASE CHAIN REACTION; RATS; RETINA; RETINAL GANGLION CELLS; RNA; RNA, MESSENGER;

EID: 0031964341     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Allcutt D, Berry M, Sievers J. A qualitative comparison of the reactions of retinal ganglion cell axons to optic nerve crush in neonatal and adult mice. Brain Res. 1984;318:231-240.
2. Allcutt D, Berry M, Sievers J. A quantitative comparison of the reactions of retinal ganglion cells to optic nerve crush in neonatal and adult mice. Brain Res. 1984;318:219-230.
3. Barron KD, McGuinness CM, Misantone LJ, Zanakis MF, Grafstein B, Murray M. RNA content of normal and axotomized retinal ganglion cells of rat and goldfish. J Comp Neurol. 1985;236:265-273.
4. Misantone LJ, Gershenbaum M, Murray M. Viability of retinal ganglion cells after optic nerve crush in adult rats. J Neurocytol. 1984;13:449-465.
5. Radius RL, Anderson DR. Retinal ganglion cell degeneration in experimental optic atrophy. Am J Ophthalmol. 1978;86:673-679.
6. Vidal-Sanz M, Villegas-Perez MP, Bray GM, Aguayo AJ. Persistent retrograde labeling of adult rat retinal ganglion cells with the carbocyanine dye diI. Exp Neurol. 1988;102:92-101.
7. Villegas-Perez MP, Vidal-Sanz M, Rasminsky M, Bray GM, Aguayo AJ. Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol. 1993;24:23-36.
8. Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res. 1993;602:304-317.
9. Sievers J, Hausmann B, Berry M. Fetal brain grafts rescue adult retinal ganglion cells from axotomy-induced cell death. J Comp Neurol. 1989;281:467-478.
10. Carmignoto G, Maffei L, Candeo P, Canella R, Comelli C. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci. 1989;9:1263-1272.
11. Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA. 1994;91:1632-1636.
12. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786.
13. Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci. 1994;14:4368-4374.
14. Garcia-Valenzuela E, Gorczyca W, Darzynkiewicz Z, Sharma SC. Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol. 1994;25:431-438.
15. Rehen SK, Linden R. Apoptosis in the developing retina: paradoxical effects of protein synthesis inhibition. Braz J Med Biol Res. 1994;27:1647-1651.
16. Levin LA, Louhab A. Retinal ganglion cell apoptosis in anterior ischemic optic neuropathy. Arch Ophthalmol. 1996;114:488-491.
17. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992; 257:967-971.
18. Levin LA, Clark JA, Johns LK. Effect of lipid peroxidation inhibition on retinal ganglion cell death. Infest Ophthalmol Vis Sci. 1996; 37:2744-2749.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
20. Levin LA, Schlamp CL, Spieldoch RL, Geszvain KM, Nickells RW. Identification of bcl-2 family genes in the rat retina. Invest Ophthalmol Vis Sci. 1997;38:2545-2553.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
22. Fleming RE, Gitlin JD. Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. J Biol Chem. 1990;265:7701-7707.
23. Sato M, Gitlin JD. Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J Biol Chem. 1991;266: 5128-5134.
24. Fleming RE, Whitman IP, Gitlin JD. Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia. Am J Physiol. 1991;260:L68-L74.
25. Jaeger JL, Shimizu N, Gitlin JD. Tissue-specific ceruloplasmin gene expression in the mammary gland. Biochem J. 1991;280:671-677.
26. Aldred AR, Grimes A, Schreiber G, Mercer JF. Rat ceruloplasmin. Molecular cloning and gene expression in liver, choroid plexus, yolk sac, placenta, and testis. J Biol Chem. 1987;262:2875-2878.
27. Klomp LWJ, Farhangrazi ZS, Dugan LL, Gitlin JD. Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest. 1996;98:207-215.
28. Doster SK, Lozano AM, Aguayo AJ, Willard MB. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron. 1991;6:635-647.
29. Takahashi Y, Miyajima H, Shirabe S, Nagataki S, Suenaga A, Gitlin JD. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet. 1996;5:81-84.
30. Monta H, Ikeda S, Yamamoto K, et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol. 1995;37:646-656.
31. Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nature Genet. 1995;9:267-272.
32. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology. 1987;37: 761-767.
33. Logan JI, Harveyson KB, Wisdom GB, Hughes AE, Archbold GP. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Q J Med. 1994;87:663-670.
34. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA. 1995;92: 2539-2543.
35. Gahlot DK, Khosla PK, Makashir PD, Vasuki K, Basu N. Copper metabolism in retinitis pigmentosa. Br J Ophthalmol. 1976;60: 770-774.
36. Marmor MF, Nelson JW, Levin AS. Copper metabolism in American retinitis pigmentosa patients. Br J Ophthalmol. 1978;62:168-171.
37. Newsome DA, Swartz M, Leone NC, Hewitt AT, Wolford F, Miller ED. Macular degeneration and elevated serum ceruloplasmin. Invest Ophthalmol Vis Sci. 1986;27:1675-1680.
38. Kawanami T, Kato T, Daimon M, et al. Hereditary caeruloplasmin deficiency - clinicopathological study of a patient. J Neurol Neurosurg Psychiatry. 1996;61:506-509.
39. Takahashi Y, Miyajima H, Shirabe S, Nagataki S, Suenaga A, Gitlin JD. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet. 1996;5:81-84.
40. Raju KS, Alessandri G, Ziehe M, Gullino PM. Ceruloplasmin, copper ions, and angiogenesis. J Natl Cancer Inst. 1982;69:1183-1188.
41. Ziehe M, Jones J, Gullino PM. Role of prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst. 1982;69:475-482.
42. Walker FJ, Fay PJ. Characterization of an interaction between protein C and ceruloplasmin. J Biol Chem. 1990;265:1834-1836.
43. Gutteridge JM. Inhibition of the Fenton reaction by the protein caeruloplasmin and other copper complexes. Assessment of ferroxidase and radical scavenging activities. Chem Biol Interact. 1985;56:113-120
44. Al Timimi DJ, Dormandy TL. The inhibition of lipid autoxidation by human caeruloplasmin. Biochem J. 1977;168:283-288.
45. Gutteridge JM. Antioxidant properties of caeruloplasmin towards iron-and copper-dependent oxygen radical formation. FEBS Lett. 1983;157:37-40.
46. Klomp LWJ, Gitlin JD. Expression of the ceruloplasmin gene in the human retina and brain - implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet. 1996;5:1989-1996.
47. Miyajima H, Takahashi Y, Kamata T, Shimizu H, Sakai N, Gitlin JD. Use of desferrioxamine in the treatment of aceruloplasminemia. Ann Neurol. 1997;41:404-407.
48. Loeffler DA, DeMaggio AJ, Juneau PL, et al. Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease. Alzheimer Dis Assoc Disord. 1994;8:190-197.
49. Loeffler DA, Lewitt PA, Juneau PL, et al. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res. 1996;738:265-274.
50. Broadley C, Hoover RL. Ceruloplasmin reduces the adhesion and scavenges superoxide during the interaction of activated polymorphonuclear leukocytes with endothelial cells. Am J Pathol. 1989; 135:647-655.
51. Krsek-Staples JA, Webster RO. Ceruloplasmin inhibits carbonyl formation in endogenous cell proteins. Free Radic Biol Med. 1993;14:115-125.
52. Noell WK. Possible mechanisms of photoreceptor damage by light in mammalian eyes. Vision Res. 1980;20:1163-1171.
53. Li ZY, Tso MO, Wang HM, Organisciak DT. Amelioration of photic injury in rat retina by ascorbic acid: a histopathologic study. Invest Ophthalmol Vis Sci. 1985;26:1589-1598.
54. Ham WT, Mueller HA, Ruffolo JJ, et al. Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr Eye Res. 1984;3:165-174.
55. Rosner M, Lam TT, Fu J, Tso MOM. Methylprednisolone ameliorates retinal photic injury in rats. Arch Ophthalmol. 1992;110: 857-861.
56. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75:241-251.
57. Myers KM, Fiskum G, Liu Y, Simmens SJ, Bredesen DE, Murphy AN. Bcl-2 protects neural cells from cyanide/aglycemia-induced lipid oxidation, mitochondrial injury, and loss of viability. J Neurochem. 1995;65:2432-2440.
58. Korsmeyer SJ, Yin XM, Oltvai ZN, Veis-Novack DJ, Linette GP. Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim Biophys Acta. 1995;1271:63-66.
59. Steinman HM. The Bcl-2 oncoprotein functions as a pro-oxidant. J Biol Chem. 1995;270:3487-3490.